Treatment Outcomes of Different Prognostic Groups of Patients on Cancer and Leukemia Group B Trial 39801: Induction Chemotherapy Followed by Chemoradiotherapy Compared with Chemoradiotherapy Alone for Unresectable Stage III Non-small Cell Lung Cancer
Year: 2009
Type: article
Source: Journal of Thoracic Oncology
Institutions: University of North Carolina at Chapel Hill, Duke University, Duke Medical Center, University of Massachusetts Chan Medical School, Roswell Park Comprehensive Cancer Center, University of Tennessee Health Science Center, University of Tennessee System, Wake Forest University Health Sciences, Wake Forest University, Rhode Island Hospital, Medical University of South Carolina, University of Chicago
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: University of Nebraska Medical Center, Ohio State University, Syracuse University, University of Missouri, University of Minnesota, Georgetown University, Dartmouth College, National Institutes of Health, University of Illinois at Urbana-Champaign, University of North Carolina at Chapel Hill, Norris Cotton Cancer Center, State University of New York Upstate Medical University, National Cancer Institute
Awards: G1072356872, G10814802, CANCER AND LEUKEMIA GROUP B, G1391839138, WUMC Cancer and Leukemia Group B, G149288587, G1570777714, BAPTIST CANCER INSTITUTE COMMUNITY CLINICAL ONCOLOGY PRO, G1689128559, G199746015, G20154349, G211333722, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B, G220937036, G2281990079, G2319677911, G237383067, G2405064429, G257334932, G260759372, Cancer and Leukemia Group B, G2647518335, Minority Based Community Clinical Oncology Program, Cancer and Leukemia Group B Statistical Center, University of Iowa CALGB Institutional Grant, G3255944410, Southeast Cancer Control Consortium, Inc, G328901006, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B--MOUNT SINAI, Cancer and Leukemia Group B, G3710026009, G4192246825, G436504642, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B, G4530377164, G4670716055, G4744150602, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B: RPMI/SUNYAB, CANCER AND LEUKEMIA GROUP B, G532797959, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B (CALGB), CANCER AND LEUKEMIA GROUP B, G639492384, Northern Indiana Cancer Research Corsoortium, CCOP, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, G7035163513, Hematology-Oncology Associates of Central New York CCOP, MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM, CANCER AND LEUKEMIA GROUP B, G739544170, CANCER AND LEUKEMIA GROUP B--MINNESOTA ONCOLOGY GROUP, Cancer and Leukemia Group B, Cancer and Leukemia Group B - The Ohio State University, Nevada Cancer Research foundation-Community Clinical Oncology Program, G8170664304, CANCER AND LEUKEMIA GROUP B, G866232813, G8665016104, G877081928, G877907214, G926666752, G973482110, G979369470
OpenAlex ID: W1980127383